Brian McNamee will step down as CEO of blood plasma company
CSL at the end of June 2013, after 23 years in the job.
CSL, which began life as the Commonwealth Serums Laboratories in 1916, was only worth $A23 million when McNamee became CEO, but it is now ...
[Published Individual.com - Jun 16 2013]